Read full report at JeffersonHealth.org
Jefferson has received $15,875,322 in federal funding to support substance use and mental health initiatives over the next five years. The awards will strengthen Jefferson’s substance use disorder and Medication for Opioid Use Disorder (MOUD) infrastructure, suicide prevention efforts, and research examining ADHD stimulant treatment patterns and substance use outcomes in adolescents.
“Addressing the growing need for mental health and substance use services requires collaboration, innovation, and sustained investment. These awards will strengthen critical community resources, expand access to care, and advance research that can improve health outcomes for generations to come,” said Baligh Yehia, MD, MPP, MSc, President, Jefferson Health
City of Philadelphia

